137 related articles for article (PubMed ID: 10798743)
1. Cyclosporine A and azathioprine are equipotent in chronic kidney allograft rejection.
Hamar P; Liu S; Viklický O; Szabó A; Múller V; Heemann U
Transplantation; 2000 Apr; 69(7):1290-5. PubMed ID: 10798743
[TBL] [Abstract][Full Text] [Related]
2. SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts.
Viklický O; Zou H; Müller V; Lacha J; Szabó A; Heemann U
Transplantation; 2000 Feb; 69(4):497-502. PubMed ID: 10708101
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
[TBL] [Abstract][Full Text] [Related]
4. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
[TBL] [Abstract][Full Text] [Related]
5. Early application of Met-RANTES ameliorates chronic allograft nephropathy.
Song E; Zou H; Yao Y; Proudfoot A; Antus B; Liu S; Jens L; Heemann U
Kidney Int; 2002 Feb; 61(2):676-85. PubMed ID: 11849411
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic renal allograft rejection in rats with a low-molecular-weight heparin (reviparin).
Braun C; Schultz M; Fang L; Schaub M; Back WE; Herr D; Laux V; Rohmeiss P; Schnuelle P; van der Woude FJ
Transplantation; 2001 Jul; 72(2):209-15. PubMed ID: 11477340
[TBL] [Abstract][Full Text] [Related]
7. Host leukocytes and their products in chronic kidney allograft rejection in rats.
Azuma H; Heemann U; Tullius SG; Tilney NL
Transpl Int; 1994; 7 Suppl 1():S325-7. PubMed ID: 11271242
[TBL] [Abstract][Full Text] [Related]
8. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
Azuma H; Chandraker A; Nadeau K; Hancock WW; Carpenter CB; Tilney NL; Sayegh MH
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12439-44. PubMed ID: 8901600
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
[TBL] [Abstract][Full Text] [Related]
10. Conversion from cyclosporin A to sirolimus retards the progression of chronic allograft nephropathy in the long term in a rat kidney transplantation model.
He Z; Chen L; Qiu J; Li J; Zhao D; Chen G; Wang C
J Int Med Res; 2009; 37(5):1396-410. PubMed ID: 19930844
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration.
Wang M; Liu S; Ouyang N; Song E; Lutz J; Heemann U
Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424
[TBL] [Abstract][Full Text] [Related]
12. Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts.
Azuma H; Binder J; Heemann U; Schmid C; Tullius SG; Tilney NL
Transplantation; 1995 Feb; 59(4):460-6. PubMed ID: 7878746
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2-dependent mechanisms are involved in the development of glomerulosclerosis after partial renal ablation in rats.
Hamar P; Peti-Peterdi J; Szabó A; Becker G; Flach R; Rosivall L; Heemann U
Exp Nephrol; 2001; 9(2):133-41. PubMed ID: 11150862
[TBL] [Abstract][Full Text] [Related]
14. Infections and reduced functioning kidney mass induce chronic rejection in rat kidney allografts.
Heemann UW; Azuma H; Tullius SG; Schmid C; Philipp T; Tilney NL
Clin Nephrol; 1996 Jul; 46(1):34-8. PubMed ID: 8832148
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
16. The effect of FK778 on the progression of chronic allograft nephropathy in a rat model.
Lutz J; Huang H; Deng M; Wagner B; Roos M; Schmaderer C; Strobl M; Heemann U
Transplantation; 2007 Mar; 83(6):741-6. PubMed ID: 17414707
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.
Jolicoeur EM; Qi S; Xu D; Dumont L; Daloze P; Chen H
Transplantation; 2003 Jan; 75(1):54-9. PubMed ID: 12544871
[TBL] [Abstract][Full Text] [Related]
18. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
19. The involvement of activated T cells and growth-factor production in the early and late phase of chronic kidney allograft nephropathy in rats.
Hamar P; Szabó A; Müller V; Heemann U
Transpl Int; 2002 Oct; 15(9-10):446-54. PubMed ID: 12389075
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin is less fibrogenic than Cyclosporin A as demonstrated in a rat model of chronic allograft nephropathy.
Luo L; Sun Z; Luo G
J Surg Res; 2013 Jan; 179(1):e255-63. PubMed ID: 22480837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
